Journal for ImmunoTherapy of Cancer (Aug 2021)
Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Aug 2021)